- Home
- HRMY vs STAA Comparison
HRMY vs STAA Comparison
Compare HRMY & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HRMY
- STAA
- Stock Information
- Founded
- HRMY 2017
- STAA 1982
- Country
- HRMY United States
- STAA United States
- Employees
- HRMY N/A
- STAA N/A
- Industry
- HRMY Biotechnology: Pharmaceutical Preparations
- STAA Ophthalmic Goods
- Sector
- HRMY Health Care
- STAA Health Care
- Exchange
- HRMY Nasdaq
- STAA Nasdaq
- Market Cap
- HRMY 1.9B
- STAA 1.3B
- IPO Year
- HRMY 2020
- STAA N/A
- Fundamental
- Price
- HRMY $34.83
- STAA $24.10
- Analyst Decision
- HRMY Buy
- STAA Buy
- Analyst Count
- HRMY 10
- STAA 7
- Target Price
- HRMY $49.80
- STAA $42.83
- AVG Volume (30 Days)
- HRMY 539.5K
- STAA 555.3K
- Earning Date
- HRMY 02-20-2025
- STAA 02-24-2025
- Dividend Yield
- HRMY N/A
- STAA N/A
- EPS Growth
- HRMY N/A
- STAA 9.97
- EPS
- HRMY 2.11
- STAA 0.44
- Revenue
- HRMY $681,879,000.00
- STAA $341,224,000.00
- Revenue This Year
- HRMY $24.83
- STAA $8.37
- Revenue Next Year
- HRMY $18.66
- STAA $11.70
- P/E Ratio
- HRMY $16.53
- STAA $54.79
- Revenue Growth
- HRMY 25.83
- STAA 10.01
- 52 Week Low
- HRMY $28.14
- STAA $23.55
- 52 Week High
- HRMY $41.61
- STAA $52.68
- Technical
- Relative Strength Index (RSI)
- HRMY 55.30
- STAA 40.03
- Support Level
- HRMY $33.36
- STAA $23.55
- Resistance Level
- HRMY $34.96
- STAA $25.04
- Average True Range (ATR)
- HRMY 1.19
- STAA 1.09
- MACD
- HRMY 0.16
- STAA 0.07
- Stochastic Oscillator
- HRMY 81.62
- STAA 23.01
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant), is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and used for the treatment of cataplexy in adult patients with narcolepsy.
About STAA STAAR Surgical Company
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of sales are generated from the ophthalmic surgical product segment.